NCT05683535View on ClinicalTrials.gov

Adverse Events Related to Low Dose Atropine

CompletedOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

January 9, 2023

Study Completion Date

January 9, 2023

Conditions
Myopia, Progressive
Interventions
DRUG

Atropine Sulfate

0.01%, 0.03%, or 0.05% atropine eye drops made from compounding pharmacies.

Trial Locations (1)

92130

Laura Kirkeby, San Diego

All Listed Sponsors
lead

Scripps Health

OTHER

NCT05683535 - Adverse Events Related to Low Dose Atropine | Biotech Hunter | Biotech Hunter